ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection

This study is currently recruiting patients.

Sponsored by: GlaxoSmithKline
Information provided by: GlaxoSmithKline

Purpose

This is a 48-week study to collect information on the safety and activity of an investigational medicine in patients, ages 2 to 18 years old, with HIV infection .

Condition Treatment or Intervention Phase
HIV Infections
 Drug: Lexiva (GW433908)
 Drug: Ritonavir
Phase II

MedlinePlus related topics:  AIDS

Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Parallel Assignment, Safety Study

Eligibility

Ages Eligible for Study:  2 Years   -   18 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion criteria:

Exclusion criteria:


Location and Contact Information


Alabama
      Birmingham,  Alabama,  35233,  United States; Recruiting
Study Coordinator  205-996-7831 

California
      Los Angeles,  California,  90033,  United States; Not yet recruiting
Study Coordinator  323-226-2342 

      Oakland,  California,  94609-1809,  United States; Not yet recruiting
Study Coordinator  510-428-3885  Ext. 2857 

Florida
      Jacksonville,  Florida,  32209,  United States; Not yet recruiting
Study Coordinator  904-244-5331 

Illinois
      Chicago,  Illinois,  60614-3394,  United States; Not yet recruiting
Study Coordinator  773-880-3669 

Massachusetts
      Boston,  Massachusetts,  02118,  United States; Not yet recruiting
Study Coordinator  617-414-7508 

New York
      New York,  New York,  10016-6481,  United States; Not yet recruiting
Study Coordinator  212-263-5680 

      New York,  New York,  10021,  United States; Not yet recruiting
Study Coordinator  212-746-3367 

      New York,  New York,  10037,  United States; Not yet recruiting
Study Coordinator  212-939-4045 

      Bronx,  New York,  10461,  United States; Not yet recruiting
Study Coordinator  718-918-4516 

      New Hyde Park,  New York,  11042,  United States; Not yet recruiting
Study Coordinator  516-465-5360 

North Carolina
      Durham,  North Carolina,  27705,  United States; Not yet recruiting
Study Coordinator  919-416-3441 

Pennsylvania
      Philadelphia,  Pennsylvania,  19134-1095,  United States; Not yet recruiting
Study Coordinator  215-427-5284 

Tennessee
      Memphis,  Tennessee,  38105-2794,  United States; Not yet recruiting
Study Coordinator  901-495-3490 

Texas
      Dallas,  Texas,  75235,  United States; Not yet recruiting
Study Coordinator  214-456-8185 

      Fort Worth,  Texas,  76104,  United States; Not yet recruiting
Study Coordinator  682-885-4073 

Belgium
      Antwerp,  B-2020,  Belgium; Not yet recruiting
Study Coordinator  011-32 3 280 2160 

Canada, Ontario
      Toronto,  Ontario,  M5G 1X8,  Canada; Not yet recruiting
Study Coordinator  416-813-7444 

      Vancouver,  Ontario,  V6H 3N1,  Canada; Not yet recruiting
Study Coordinator  604-875-2463 

Canada, Quebec
      Montreal,  Quebec,  H3T 1C5,  Canada; Not yet recruiting
Study Coordinator  514-345-4836 

Russian Federation
      Moscow,  105275,  Russian Federation; Not yet recruiting
Study Coordinator  0117 095 366 62 38 

      Moscow,  129110,  Russian Federation; Not yet recruiting
Study Coordinator  0117 095 681 3717 

      St Petersburg,  196645,  Russian Federation; Not yet recruiting
Study Coordinator  0117 812 464 9329 

Spain
      Palma de Mallorca,  07014,  Spain; Not yet recruiting
Study Coordinator  011 34 971 175000  Ext. 75998 

      Malaga,  29011,  Spain; Not yet recruiting
Study Coordinator  01134 952030100 

      Murcia,  30120,  Spain; Not yet recruiting
Study Coordinator  011-34968369602 

      Sevilla,  41013,  Spain; Not yet recruiting
Study Coordinator  01134 955012991 

      Barcelona,  08950,  Spain; Not yet recruiting
Study Coordinator  01134 93 253 21 30  Ext. 2354 

      Barcelona,  25-2908003,  Spain; Not yet recruiting
Study Coordinator  01134 93 248 31 48 

      Madrid,  28041,  Spain; Not yet recruiting
Study Coordinator  01134 91 390 8569  Ext. 75998 

      Madrid,  28046,  Spain; Not yet recruiting
Study Coordinator  01134 91 727 74 43 

      Valencia,  46009,  Spain; Not yet recruiting
Study Coordinator  011 34 96 1973244  Ext. 50254 

Spain, Pontevedra
      Vigo,  Pontevedra,  36204,  Spain; Not yet recruiting
Study Coordinator  01134 986 816000  Ext. 15204 

More Information

Study ID Numbers:  APV29005
Record last reviewed:  September 2004
Record first received:  August 6, 2004
ClinicalTrials.gov Identifier:  NCT00089583
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2004-10-22
line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act